Global Handheld Melanoma Scanner Market is set to reach USD 650 million by 2025

Posted on 2018-04-26 by Goldstein Research in Healthcare // 0 Comments

New York, USA, 2018-Apr-26 — /EPR Network/ — According to Goldstein Research, global handheld melanoma scanner market is expected to reach USD 650 million by 2025, expanding at a CAGR of 8.12% over the forecast period, 2017-2025. The growing skin cancer therapeutics market with increasing prevalence of melanoma skin cancer cases is majorly driving the market growth. Global handheld melanoma scanner market segmentation has been done on the basis of patient group skin melanoma, end-user and geography. Superficial spreading melanoma comprised 65% market share of total patient group skin melanoma’s, which often arises in a pre-existing mole and grows parallel before invading in upright manner. Global Handheld melanoma scanner market is dominated by North America region owing to increasing cases of melanoma and presence of handheld melanoma scanner manufacturers in the region. Further, several non-invasive, automated, hand-held optical scanners have been developed to help dermatologists determine whether a skin biopsy is indicated, is driving the Handheld Melanoma Scanner market in Europe and APAC regions.

Browse Full Report: https://www.goldsteinresearch.com/report/global-handheld-melanoma-scanner-market

Market Segmentation

On the basis of our in-depth analysis, Global Handheld Melanoma Scanner Market can be segmented as follows:

By Patient Group Skin Melanoma

Superficial Spreading Melanoma
Nodular Melanoma
Lentigo Maligna
Acral Lentiginous Melanoma

By End User

Hospitals
Clinics
Cancer Research Organizations

By region

North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
Global (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Global) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Asia Pacific (China, Japan, India, Singapore, South Korea, Global, New Zealand and Rest of Global) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

“Global Handheld Melanoma Scanner Market Outlook 2024” contains detailed overview of the Global Handheld melanoma scanner market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by patient group skin melanoma and end-users.

Further, for the in-depth analysis, Handheld Melanoma Scanner Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This industry analysis report also includes competitive outlook of some of the major players profiling of companies such as Strata Skin Sciences, Verisante, MedX Health, Abbott Laboratory, Medtronic, Siemens AG, Baxter International Inc., Agilent Technology, Roche, AstraZeneca, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents the Global Handheld melanoma scanner market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/global-handheld-melanoma-scanner-market

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Global, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare industry research reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

By Patient Group Skin Melanoma

By End User

By region

About Goldstein Research

Matched content

Editor’s pick